Cancer (Oncology) Clinical Trials

Clinical Trials

Clinical Trials Phase

Clinical Trials Sites

Clinical Trials Primary Purpose

Ages

Search for ‘pediatric oncology’ results: 1-11 of 11

Pediatric Oncology
ALTE07C1: Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer
UVA-Gen001: A Randomized, Placebo-Controlled Pilot Study of Genistein Supplementation in Pediatric Cancer Patients Receiving Myelosuppressive Chemotherapy
ANBL1232: Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk Neuroblastoma
APEC14B1: The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
GD2 BAT: Treatment of Neuroblastoma and GD2-Positive Tumors with Activated T Cells Armed with OKT3 X Humanized 3F8 Bispecific Antibodies (GD2Bi): A Phase I/II Study
SuperLeuk: Collection of Bone Marrow Samples from Pediatric Patients with Leukemia, Lymphoma, Aplastic Anemia, and Immune Thrombocytopenic Purpura
AflacST1502: A Phase II Study of Sirolimus in Combination with Metronomic Chemotherapy in Children with Recurrent and/or Refractory Solid and CNS Tumors
ANBL00B1: Neuroblastoma Biology Studies: a Children's Oncology Group Study
ZUMA-4: A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Pediatric and Adolescent Subjects with Philadelphia Chromosome-Negative Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL)
AALL1631, International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
AALL1731_A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)